Search
Tonix Pharmaceuticals Holding Corp
TNXPAdd to Watchlist
12.340USD
-0.100-0.80%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
157.80MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Tonix Pharmaceuticals Holding Corp is 8.50, ranking 33 out of 157 in the Pharmaceuticals industry. The average price target is 65.00, with a high of 70.00 and a low of 64.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
42.200
Target Price
+239.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Tonix Pharmaceuticals Holding Corp
TNXP
4
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Tonix Pharmaceuticals Holding Corp's expected revenue for the next quarter?
Tonix Pharmaceuticals Holding Corp's expected revenue is 7.72M.
What is Tonix Pharmaceuticals Holding Corp's price target?
Analysts forecast that Tonix Pharmaceuticals Holding Corp's price target is USD 65.00, with the highest forecast at USD 70.00 and the lowest forecast at USD 64.00.
How have Tonix Pharmaceuticals Holding CorpTNXP's recent earnings per share performed?
The market expectation was USD -2.93, while Tonix Pharmaceuticals Holding CorpTNXP's earnings per share (EPS) for the previous quarter was USD -3.96. EPS for the next quarter is expected at USD -2.70.
What is the analyst rating for Tonix Pharmaceuticals Holding Corp?
Based on the ratings of Tonix Pharmaceuticals Holding Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.